Published in Biotech Law Weekly, May 5th, 2006
Study 1: Early quinapril or losartan improved both diabetic autonomic neuropathy and left ventricular diastolic dysfunction in asymptomatic patients with type 1 or 2 diabetes mellitus, after 1 year of treatment.
In a recently published article, scientists in Greece conducted a study "to investigate the effect of angiotensin converting enzyme inhibition (ACE-I) or angiotensin receptor blockade (ARB), and their combination, on both diabetic autonomic neuropathy (DAN) and left ventricular (LV) diastolic dysfunction (LVDD) in asymptomatic patients with diabetes mellitus...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.